BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 16048353)

  • 1. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.
    Hargreaves IP; Duncan AJ; Heales SJ; Land JM
    Drug Saf; 2005; 28(8):659-76. PubMed ID: 16048353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ
    Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statin drugs decrease the plasma level of coenzyme Q10 (ubiquinone) in the organism].
    Rákóczi K; Párdutz A; Vécsei L
    Ideggyogy Sz; 2007 Jul; 60(7-8):295-300. PubMed ID: 17713110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q(10) and statin myalgia: what is the evidence?
    Mas E; Mori TA
    Curr Atheroscler Rep; 2010 Nov; 12(6):407-13. PubMed ID: 20725809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquinone: cholesterol's reclusive cousin.
    Hargreaves IP
    Ann Clin Biochem; 2003 May; 40(Pt 3):207-18. PubMed ID: 12803831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin decreased coenzyme Q in the left ventricle and skeletal muscle but not in the brain and liver in L-NAME-induced hypertension.
    Kucharská J; Gvozdjáková A; Simko F
    Physiol Res; 2007; 56 Suppl 2():S49-S54. PubMed ID: 17824807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for supplementing with coenzyme Q10 during statin therapy.
    Levy HB; Kohlhaas HK
    Ann Pharmacother; 2006 Feb; 40(2):290-4. PubMed ID: 16449543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coenzyme Q10 and statins: biochemical and clinical implications.
    Littarru GP; Langsjoen P
    Mitochondrion; 2007 Jun; 7 Suppl():S168-74. PubMed ID: 17482884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q10 in patients undergoing CABG: Effect of statins and nutritional supplementation.
    Keith M; Mazer CD; Mikhail P; Jeejeebhoy F; Briet F; Errett L
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):105-11. PubMed ID: 17368873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoQ10 and L-carnitine for statin myalgia?
    DiNicolantonio JJ
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1329-33. PubMed ID: 23190071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease.
    Lieberman A; Lyons K; Levine J; Myerburg R
    Parkinsonism Relat Disord; 2005 Mar; 11(2):81-4. PubMed ID: 15734664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy.
    Young JM; Molyneux SL; Reinheimer AM; Florkowski CM; Frampton CM; Scott RS; George PM
    Atherosclerosis; 2011 Sep; 218(1):188-93. PubMed ID: 21640350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
    Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
    J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users.
    Schaars CF; Stalenhoef AF
    Curr Opin Lipidol; 2008 Dec; 19(6):553-7. PubMed ID: 18957876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?
    Tavintharan S; Ong CN; Jeyaseelan K; Sivakumar M; Lim SC; Sum CF
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):173-9. PubMed ID: 17610923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reduced synthesis of coenzyme Q10 may cause statin related myopathy].
    Nielsen ML; Pareek M; Henriksen JE
    Ugeskr Laeger; 2011 Nov; 173(46):2943-8. PubMed ID: 22094213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.